Study protocol and implementation details for a pragmatic, stepped-wedge cluster randomised trial of a digital adherence technology to facilitate tuberculosis treatment completion

dc.contributor.authorCrowder, Rebecca
dc.contributor.authorKityamuwesi, Alex
dc.contributor.authorKiwanuka, Noah
dc.contributor.authorLamunu, Maureen
dc.contributor.authorNamale, Catherine
dc.contributor.authorKunihira Tinka, Lynn
dc.contributor.authorSanyu Nakate, Agnes
dc.contributor.authorGgita, Joseph
dc.contributor.authorTurimumahoro, Patricia
dc.contributor.authorBabirye, Diana
dc.contributor.authorOyuku, Denis
dc.contributor.authorAllen Berger, Christopher
dc.contributor.authorTucker, Austin
dc.contributor.authorPatel, Devika
dc.contributor.authorSammann, Amanda
dc.contributor.authorDowdy, David
dc.contributor.authorTuryahabwe, Stavia,
dc.contributor.authorCattamanchi, Adithya
dc.contributor.authorKatamba, Achilles
dc.date.accessioned2023-01-19T18:09:48Z
dc.date.available2023-01-19T18:09:48Z
dc.date.issued2020
dc.description.abstractLow-cost digital adherence technologies (DATs) such as 99DOTS have emerged as an alternative to directly observed therapy (DOT), the current standard for tuberculosis (TB) treatment supervision. However, there are limited data to support DAT scale-up. The ‘DOT to DAT’ trial aims to evaluate the effectiveness and implementation of a 99DOTS-based TB treatment supervision strategy. Methods and analysis This is a pragmatic, stepped-wedge cluster randomised trial, with hybrid type 2 effectiveness-implementation design. The trial will include all adults (estimated N=1890) treated for drug-susceptible pulmonary TB over an 8-month period at 18 TB treatment units in Uganda. Three sites per month will switch from routine care (DOT) to the intervention (99DOTS-based treatment supervision) beginning in month 2, with the order determined randomly. 99DOTS enables patients to be monitored while self-administering TB medicines. Patients receive daily automated short message service (SMS) dosing reminders and confirm dosing by calling toll-free numbers. The primary effectiveness outcome is the proportion of patients completing TB treatment. With 18 clusters randomised into six steps and an average cluster size of 15 patients per month, the study will have 89% power to detect a 10% or greater increase in treatment completion between the routine care and intervention periods. Secondary outcomes include more proximal effectiveness measures as well as quantitative and qualitative assessments of the reach, adoption and implementation of the intervention. Ethics and dissemination Ethics approval was granted by institutional review boards at Makerere University School of Public Health and the University of California San Francisco. Findings will be disseminated through peer-reviewed publications, presentations at scientific conferences and presentations to key stakeholders.en_US
dc.identifier.citationCrowder R, Kityamuwesi A, Kiwanuka N, et al. Study protocol and implementation details for a pragmatic, stepped-wedge cluster randomised trial of a digital adherence technology to facilitate tuberculosis treatment completion. BMJ Open 2020;10:e039895. doi:10.1136/ bmjopen-2020-039895en_US
dc.identifier.uri10.1136/ bmjopen-2020-039895
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/7077
dc.language.isoenen_US
dc.publisherBMJ Openen_US
dc.subjectStudy protocolen_US
dc.subjectStepped-wedge clusteren_US
dc.subjectDigital adherence technologyen_US
dc.subjectTuberculosis treatmenten_US
dc.titleStudy protocol and implementation details for a pragmatic, stepped-wedge cluster randomised trial of a digital adherence technology to facilitate tuberculosis treatment completionen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Study protocol and implementation.pdf
Size:
778.82 KB
Format:
Adobe Portable Document Format
Description:
Article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: